DICYCLOMINE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for dicyclomine hydrochloride and what is the scope of freedom to operate?
Dicyclomine hydrochloride
is the generic ingredient in four branded drugs marketed by Allergan, Annora Pharma, Aurobindo Pharma Usa, Corepharma, Lannett, Pioneer Pharms, Prinston Inc, Sun Pharm Industries, Twi Pharms, Watson Labs, West Ward, Abbvie, Am Regent, Dr Reddys, Fosun Pharma, Fresenius Kabi Usa, Hikma, Nexus, Praxgen Pharms, Renew Pharms, Slate Run Pharma, Aptalis Pharma Us, Alpharma Us Pharms, Endo Operations, Novitium Pharma, Bionpharma, Hikma Pharms, and Rubicon, and is included in forty NDAs. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for dicyclomine hydrochloride. Fifty-four suppliers are listed for this compound.
Summary for DICYCLOMINE HYDROCHLORIDE
US Patents: | 0 |
Tradenames: | 4 |
Applicants: | 28 |
NDAs: | 40 |
Drug Master File Entries: | 4 |
Finished Product Suppliers / Packagers: | 54 |
Raw Ingredient (Bulk) Api Vendors: | 63 |
Patent Applications: | 1,516 |
What excipients (inactive ingredients) are in DICYCLOMINE HYDROCHLORIDE? | DICYCLOMINE HYDROCHLORIDE excipients list |
DailyMed Link: | DICYCLOMINE HYDROCHLORIDE at DailyMed |
Pharmacology for DICYCLOMINE HYDROCHLORIDE
Drug Class | Anticholinergic |
Mechanism of Action | Cholinergic Antagonists |
Medical Subject Heading (MeSH) Categories for DICYCLOMINE HYDROCHLORIDE
US Patents and Regulatory Information for DICYCLOMINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aptalis Pharma Us | BENTYL | dicyclomine hydrochloride | SYRUP;ORAL | 007961-002 | Oct 15, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Corepharma | DICYCLOMINE HYDROCHLORIDE | dicyclomine hydrochloride | TABLET;ORAL | 216760-001 | Nov 28, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Watson Labs | DICYCLOMINE HYDROCHLORIDE | dicyclomine hydrochloride | CAPSULE;ORAL | 085082-001 | Jun 19, 1986 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.